Gail Eckhardt, University of Colorado Cancer Center

S. Gail Eckhardt, MD, is one of three nominated for President of American Society for Clinical Oncology.

The American Society of Clinical Oncology (ASCO) recently announced the short list of candidates running for organization leadership, including S. Gail Eckhardt, MD, FASCO, associate director for translational research at the University of Colorado Cancer Center and the Stapp Harlow Chair in Cancer Research at the CU School of Medicine, who is one of three nominees for ASCO President. With more than 35,000 members, ASCO is the country’s premier organization of practicing oncologists, with a mission to conquer cancer through research, education, prevention and delivery of high-quality patient care.

Dr. Eckhardt’s nomination follows many years of involvement with the organization. An ASCO member since 1994, Dr. Eckhardt has served most recently on the New Drugs in Oncology Seminar Planning Committee (2013-2014), the ASCO Connection Editorial Board (2008-2013), and the ASCO-American Association for Cancer Research (AACR) Methods in Clinical Cancer Research Workshop Program Committee (2005-2012). She has served on the ASCO Board of Directors, was Co-Chair of the Molecular Oncology Task Force, and Chair of the Gastrointestinal Cancers Symposium Steering Committee, among other positions. She served as Course Director for the ASCO-AACR Methods in Clinical Cancer Research Workshop for four years, and in 2014 and 2015 she was awarded the Merrill J. Egorin Outstanding Mentor of the Year Award.

“I was nominated for the ASCO presidency around the time of my service on the ASCO Board but at the time my sons were still at home and I was very committed to maximizing the time I had left with them,” Eckhardt says.

Dr. Eckhardt’s expertise includes the three important components of preclinical and early clinical research, clinical patient care, and organizational leadership. If elected, Eckhardt hopes to focus on developing best practices for the acceleration of drug development, training enough oncologists to keep pace with the growing need for cancer care, and ensuring equity in access to personalized, patient-centered care across ethnic, religious, socioeconomic and gender lines.

“Becoming ASCO President provides an unparalleled opportunity to be part of a collaborative effort to shape global cancer research and care and greatly impact patients. Being considered for this position is a great honor,” Eckhardt says.

Eligible ASCO members can vote from November 3 – December 3 at